Clinical Trial Update: Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis [NA]

View source ↗

Summary

Bayer-sponsored completed clinical trial evaluating a new revised topical formulation for atopic dermatitis, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Bayer | Conditions: Dermatitis, Atopic | NA | Status: COMPLETED